CD276 抗体 (AA 484-534)
Quick Overview for CD276 抗体 (AA 484-534) (ABIN1977467)
抗原
See all CD276 抗体适用
宿主
克隆类型
标记
应用范围
- 
    
- 
                                            
抗原表位
 - AA 484-534
 - 
                                            
特异性
 - Region between residue 484 to 534 of human CD276 Molecule using the numbering given in entry NP_001019907.1 (GeneID 80381).
 - 
                                            
纯化方法
 - Immunoaffinity purified
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
应用备注
 - 
                        Approved: IP (2 - 10 μg/mg lysate)
Not recommended for: WB - 
                                            
说明
 - 
                        
Target Species of Antibody: Human
 - 
                                            
限制
 - 仅限研究用
 
 - 
                                            
 - 
    
- 
                                            
状态
 - Liquid
 - 
                                            
浓度
 - Lot specific
 - 
                                            
缓冲液
 - Tris-citrate/phosphate buffer, pH 7-8, 0.09 % sodium azide.
 - 
                                            
储存液
 - Sodium azide
 - 
                                            
注意事项
 - This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
 - 
                                            
储存条件
 - 4 °C
 - 
                                            
储存方法
 - Store at 2-8°C for up to 1 year.
 - 
                                            
有效期
 - 12 months
 
 - 
                                            
 - 
    
- CD276
 - 
                                            
别名
 - CD276 / B7-H3
 - 
                                            
背景
 - 
                        Name/Gene ID: CD276
Synonyms: CD276, 4Ig-B7-H3, B7 homolog 3, B7-H3, CD276 antigen, CD276 Molecule, Costimulatory molecule, B7H3, B7RP-2 - 
                                            
基因ID
 - 80381
 - 
                                            
途径
 - Cancer Immune Checkpoints
 
抗原
 -